Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qt Imaging Holdings (QTI) Cash from Restructuring (2024)

Qt Imaging Holdings (QTI) reported Cash from Restructuring of -$20349.0 for Q4 2024, down 656.74% on a QoQ basis from $3655.0 in Q2 2024.

Qt Imaging Holdings (QTI) has 1 years of Cash from Restructuring data on file, last reported at -$20349.0 in Q4 2024.

  • Quarterly Cash from Restructuring changed N/A year-over-year to -$20349.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$20349.0 (down 100.55% YoY) and the FY2024 annual result came in at $3.7 million, changed N/A from the prior year.
  • Cash from Restructuring fell to -$20349.0 in Q4 2024 per QTI's latest filing, from $3655.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $3.7 million in Q1 2024 and bottomed at -$20349.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Qt Imaging Holdings 67.06 Mn 67.06 Mn 2.67 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -20,349.00
Jun 30, 2024 3,655.00
Mar 31, 2024 3.71 Mn